Narrow-moat Demant DEMANT announced that the U.K. Competition and Markets Authority’s provisional finding (prior to the final report in early June) is that the divestment of Oticon Medical to Cochlear ...

Cochlear Ltd. will acquire Danish hearing implant company Oticon Medical A/S for AU$170 million (US$121 million) after parent company the Demant Group said it planned to exit its hearing implants ...

SOMERSET, N.J.--(BUSINESS WIRE)--Oticon Medical today announced that the US Food and Drug Administration (FDA) has granted premarket approval (PMA) to the company’s Neuro System to treat individuals ...

The merger of 2 leading providers of hearing implants could lead to higher prices for the NHS, and reduced quality and slower innovation for UK patients who rely on these life-changing devices. The ...

The U.K.’s Competition and Markets Authority is escalating its investigation into Cochlear’s planned acquisition of Demant subsidiary Oticon Medical, based on concerns that the merger could stanch ...

The Competition and Markets Authority (CMA) has prevented part of a merger between two of the biggest players in the UK's hearing implant sector. This action will avoid worse outcomes for patients, ...

The Competition and Markets Authority (CMA) found a merger between two of the biggest players in the UK's hearing implant sector could lead to worse outcomes for the patients who rely on these ...

A cochlear implant is a small and complex electronic device which helps patients who are deaf or hard-of-hearing get a sense of sound. BURLINGAME, CA, UNITED STATES, February 3, 2025 /EINPresswire / - ...

The Cochlear Limited (ASX: COH) share price is edging lower today. In morning trade, the hearing solutions company's shares are down 1% to $234. Why is the Cochlear share price falling? This weakness ...

April 20 (Reuters) - A UK regulator said on Thursday that Australian hearing device maker Cochlear's COH.AX acquisition of Demant's DEMANT.CO hearing implants unit could hurt competition and lead to ...